131
Views
23
CrossRef citations to date
0
Altmetric
Letters

Immunohistological features of hip synovitis in ankylosing spondylitis with advanced hip involvement

, , , , , , , , & show all
Pages 154-155 | Accepted 14 Aug 2008, Published online: 12 Jul 2009

References

  • Khan M. A., van der Linden S. M. Ankylosing spondylitis and other spondyloarthropathies. Rheumatol Clin North Am 1990; 16: 551–79
  • Calin A., Elswood J. The relationship between pelvic, spinal and hip involvement in ankylosing spondylitis: one disease process or several?. Br J Rheumatol 1988; 27: 393–5
  • Kidd B. L., Moore K., Walters M. T., Smith J. L., Cawley M. I. D. Immunohistological features of synovitis in ankylosing spondylitis: a comparison with rheumatoid arthritis. Ann Rheum Dis 1989; 48: 92–8
  • Cunnane G., Bresnihan B., FitzGerald O. Immunohistologic analysis of peripheral joint disease in ankylosing spondylitis. Arthritis Rheum 1998; 41: 180–2
  • Baeten D., Kruithof E., Rycke L., Boots A. M., Mielants H., Veys E. M., et al. Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathy. Arthritis Res Ther 2005; 7: R359–69
  • Chen C. H., Lin K. C., Yu D. T. Y., Yang C., Huang F., Chen H. A., et al. Serum matrix metalloproteinases and tissue inhibitor of metalloproteinases in ankylosing spondylitis: MMP‐3 is a reproducibly sensitive and specific biomarker of disease activity. Rheumatology 2006; 45: 414–20
  • Yang C., Gu J., Rihl M., Baeten D., Huang F., Zhao M., et al. Serum levels of matrix metalloproteinase 3 and macrophage colony‐stimulating factor 1 correlate with disease activity in ankylosing spondylitis. Arthritis Rheum 2004; 51: 691–9
  • Appel H., Kuhne M., Spiekermann S., Kohler D., Zacher J., Stein H., et al. Immunohistochemical analysis of hip arthritis in ankylosing spondylitis. Arthritis Rheum 2006; 54: 1805–13
  • Tak P. P., Van der Lubbe P. A., Cauli A., Daha M. R., Smeets T. J. M., Kluin P. M., et al. Reduction of synovial inflammation after anti‐CD4 monoclonal antibody treatment in early rheumatoid arthritis. Arthritis Rheum 1995; 38: 1457–65
  • Kruithof E., Baeten D., Van den Bosch F., Mielants H., Veys E. M., De Keyser F. Histological evidence that infliximab treatment leads to downregulation of inflammation and tissue remodeling of the synovial membrane in spondyloarthropathy. Ann Rheum Dis 2005; 64: 529–36

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.